|
Grifols, your distribution partner in Spain
Grifols philosophy is always to build long-term relationships. We are ready to start the journey to build ours.
Contact Us | |
|
|
|
Why Grifols?
Grifols is a leading global healthcare company that develops plasma-derived medicines and other innovative biopharmaceutical solutions. Grifols corporation revenue in 2022 was more than 6 billion Euro.
Being an international pharmaceutical company with the headquarters in Spain provides any Spanish organisation with unquestionable capabilities and advantages. Rigor. Innovation. Quality. Financial strength.
Grifols' Spanish commercial affiliate has a headcount of more than 200 people. Among others, we can offer to your organization: |
 |
Specialised and dedicated Commercial sales force. A team of more than 90 representatives with a high degree of specialisation and training. | |
|
 |
Strong relationships with KOL and HCPs. | |
|
 |
Own Regulatory. Lower time to market. Grifols centralised regulatory team, composed by more than 50 pharmacists, allows to easily register any pharmaceutical or sterile product in Spain. | |
|
 |
Own Logistics resources. Grifols in Spain manages more than 3,500 product references with daily deliveries to more than 500 hospitals. | |
|
|
|
For more information, please visit www.grifols.com |
Grifols provides healthcare solutions in the following areas:
|
|
Medical devices |
Such as instrumentation and disposable materials for a range of hospital services, including interventional neuroradiology, haemodynamics, urology, anaesthesiology, and cardiovascular surgery. | |
|
|
Intravenous solutions |
To maintain or restore fluids and electrolyte balance in patients and as a vehicle for medications. | |
|
|
Medication management |
To automate key hospital processes for more efficient medication management and higher-quality patient care. | |
|
|
Clinical nutrition |
Including a broad portfolio of enteral formulas and a wide variety of devices for delivering nutrition and medication to the patient. | |
|
|
|
|
GNL-HOSP-2300003
Date of preparation May 2023
©2023 Grifols. All rights reserved. | |
|
|
|